62 PHASE II HCVac STUDY OF TG4040 IMMUNOTHERAPEUTIC IN COMBINATION WITH PEGIFNa2a AND RIBAVIRIN IN GENOTYPE 1 CHC TREATMENT NAÏVE PATIENTS: SVR24 FINAL RESULTS
| Autor: | Wedemeyer, H., Janczewska Kazek, E., Wlodzimierz, M., Stanciu, C., Habersetzer, F., Carreno, V., Di Bisceglie, A., Tanasescu, C., Flisiak, R., Romero-Gomez, M., Fich, A., Hennequi, M., Bain, C., Zerr, P., Agathon, D., Adda, N., Bonnefoy, J.-Y., Inchauspé, G., Ancian, P., Limacher, J.-M. |
|---|---|
| Zdroj: | In Journal of Hepatology April 2013 58 Supplement 1:S28-S28 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect